Transplant Trial Watch.
作者信息
Knight Simon R, O'Callaghan John M, Fallon John
机构信息
Centre for Evidence in Transplantation, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom.
出版信息
Transpl Int. 2024 Jun 24;37:13360. doi: 10.3389/ti.2024.13360. eCollection 2024.
Abstract
摘要
相似文献
1
Transplant Trial Watch.移植试验观察
Transpl Int. 2024 Jun 24;37:13360. doi: 10.3389/ti.2024.13360. eCollection 2024.
2
Transplant Trial Watch.移植试验观察
Transpl Int. 2024 Jul 22;37:13457. doi: 10.3389/ti.2024.13457. eCollection 2024.
3
Transplant Trial Watch.移植试验观察
Transpl Int. 2024 Sep 30;37:13746. doi: 10.3389/ti.2024.13746. eCollection 2024.
4
Transplant Trial Watch.移植试验观察
Transpl Int. 2024 Aug 26;37:13593. doi: 10.3389/ti.2024.13593. eCollection 2024.
5
Transplant Trial Watch.移植试验观察
Transpl Int. 2024 Apr 26;37:13111. doi: 10.3389/ti.2024.13111. eCollection 2024.
6
Transplant Trial Watch.移植试验观察
Transpl Int. 2024 May 31;37:13211. doi: 10.3389/ti.2024.13211. eCollection 2024.
7
Mycophenolate mofetil--a new immunosuppressant for organ transplantation.霉酚酸酯——一种用于器官移植的新型免疫抑制剂。
Med Lett Drugs Ther. 1995 Sep 29;37(958):84-6.
8
Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.冬虫夏草（一种传统中药）用于肾移植受者。
Cochrane Database Syst Rev. 2015 Oct 12;2015(10):CD009698. doi: 10.1002/14651858.CD009698.pub2.
9
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.肾移植中新型免疫抑制方案的临床疗效与成本效益：一项系统评价与模型研究
Health Technol Assess. 2005 May;9(21):1-179, iii-iv. doi: 10.3310/hta9210.
10
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.霉酚酸与硫唑嘌呤作为肾移植受者的初始免疫抑制治疗比较
Cochrane Database Syst Rev. 2015 Dec 3;2015(12):CD007746. doi: 10.1002/14651858.CD007746.pub2.
本文引用的文献
1
Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: Results from a randomized controlled study.霉酚酸酯抑制肾移植受者对广泛疫苗的抗体反应：一项随机对照研究的结果。
J Infect. 2024 Mar;88(3):106133. doi: 10.1016/j.jinf.2024.106133. Epub 2024 Mar 2.
2
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY.在英国，接受三剂或更多剂 COVID-19 疫苗的免疫功能低下个体的抗体阳性率：来自 MELODY 的一项横断面研究。
Lancet Rheumatol. 2023 Aug;5(8):e461-e473. doi: 10.1016/S2665-9913(23)00160-1. Epub 2023 Jul 24.
3
Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study.他克莫司单药治疗在免疫低危肾移植受者中是安全的：一项随机对照的初步研究。
Transpl Int. 2022 Oct 24;35:10839. doi: 10.3389/ti.2022.10839. eCollection 2022.
4
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.肾移植受者停用或减量钙调神经磷酸酶抑制剂
Cochrane Database Syst Rev. 2017 Jul 21;7(7):CD006750. doi: 10.1002/14651858.CD006750.pub2.
5
Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review.肾移植受者早期撤停或完全避免使用类固醇：系统评价。
Nephrol Dial Transplant. 2012 Feb;27(2):825-32. doi: 10.1093/ndt/gfr374. Epub 2011 Jul 22.
Zotero 插件